Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
130
Frequently Asked Questions
What is Market Cap of Zenas Biopharma Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Zenas Biopharma Inc. market cap is $1.17B.
What is the 52-week high for Zenas Biopharma Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Zenas Biopharma Inc. 52 week high is $28.72 as of October 10, 2025.
What is the 52-week low for Zenas Biopharma Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Zenas Biopharma Inc. 52 week low is $5.83 as of October 10, 2025.
What is Zenas Biopharma Inc. stock price today?
Zenas Biopharma Inc. stock price today is $27.92.
What was Zenas Biopharma Inc. stock price yesterday?
Zenas Biopharma Inc. stock price yesterday was $27.76.
What is the PE ratio of Zenas Biopharma Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Zenas Biopharma Inc.’s P/E ratio is -6.56.
What is the Price-to-Book ratio of Zenas Biopharma Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Zenas Biopharma Inc. P/B ratio is 4.8759.
What is the 50-day moving average of Zenas Biopharma Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Zenas Biopharma Inc. 50-day moving average is $18.63.
